Your browser doesn't support javascript.
loading
Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
Cui, Huiru; Giuliano, Anthony J; Zhang, Tianhong; Xu, Lihua; Wei, Yanyan; Tang, Yingying; Qian, Zhenying; Stone, Lena M; Li, Huijun; Whitfield-Gabrieli, Susan; Niznikiewicz, Margaret; Keshavan, Matcheri S; Shenton, Martha E; Wang, Jijun; Stone, William S.
Afiliação
  • Cui H; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Giuliano AJ; Worcester Recovery Center & Hospital, Massachusetts Department of Mental Health, MA, USA.
  • Zhang T; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Xu L; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wei Y; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Tang Y; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Qian Z; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Stone LM; McLean Hospital, Schizophrenia and Bipolar Disorder Research Program, Belmont, MA, USA.
  • Li H; Florida A&M University, Department of Psychology, Tallahassee, FL, USA.
  • Whitfield-Gabrieli S; Department of Psychology, Northeastern University, Boston, MA, USA.
  • Niznikiewicz M; Department of Psychology, Northeastern University, Boston, MA, USA; Department of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.
  • Keshavan MS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Shenton ME; Department of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Research and Development, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA.
  • Wang J; Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: jijunwang27@163.com.
  • Stone WS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: wstone@bidmc.harvard.edu.
Schizophr Res ; 226: 138-146, 2020 12.
Article em En | MEDLINE | ID: mdl-32694037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Schizophr Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Schizophr Res Ano de publicação: 2020 Tipo de documento: Article